As on Thursday, Seelos Therapeutics Inc (NASDAQ: SEEL) started slowly as it slid -10.32% to $0.33, before settling in for the price of $0.37 at the close. Taking a more long-term approach, SEEL posted a 52-week range of $0.22-$292.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of -20.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 62.30%. This publicly-traded company’s shares outstanding now amounts to $6.24 million, simultaneously with a float of $5.92 million. The organization now has a market capitalization sitting at $2.06 million. At the time of writing, stock’s 50-day Moving Average stood at $0.5135, while the 200-day Moving Average is $7.2099.
Seelos Therapeutics Inc (SEEL) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Seelos Therapeutics Inc’s current insider ownership accounts for 5.20%, in contrast to 3.42% institutional ownership. According to the most recent insider trade that took place on Nov 30 ’23, this organization’s Chief Financial Officer bought 83,000 shares at the rate of 1.21, making the entire transaction reach 100,222 in total value, affecting insider ownership by 86,450. Preceding that transaction, on Dec 01 ’23, Company’s insider bought 75,757 for 1.32, making the whole transaction’s value amount to 99,999. This particular insider is now the holder of 185,142 in total.
Seelos Therapeutics Inc (NASDAQ: SEEL) Trading Performance Indicators
Let’s observe the current performance indicators for Seelos Therapeutics Inc (SEEL). It’s Quick Ratio in the last reported quarter now stands at 0.08. The Stock has managed to achieve an average true range (ATR) of 0.07. Alongside those numbers, its PE Ratio stands at $0.03, and its Beta score is 1.86. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.02.
In the same vein, SEEL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 11.04.
Technical Analysis of Seelos Therapeutics Inc (SEEL)
Through scrutinizing the latest numbers posted by the [Seelos Therapeutics Inc, SEEL], it can be observed that its last 5-days Average volume of 14.99 million was better the volume of 0.79 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 53.03% While, its Average True Range was 0.0707.
Raw Stochastic average of Seelos Therapeutics Inc (SEEL) in the period of the previous 100 days is set at 2.38%, which indicates a major fall in contrast to 45.60% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 230.02% that was higher than 139.38% volatility it exhibited in the past 100-days period.
